<DOC>
	<DOCNO>NCT01584206</DOCNO>
	<brief_summary>Ezetimibe become treatment choice patient sitosterolemia . Ezetimibe inhibitor cholesterol absorption gastrointestinal tract . The purpose study determine ezetimibe improves whole body plant sterol cholesterol homeostasis .</brief_summary>
	<brief_title>Sitosterolemia Metabolism</brief_title>
	<detailed_description />
	<mesh_term>Hypercholesterolemia</mesh_term>
	<mesh_term>Intestinal Diseases</mesh_term>
	<mesh_term>Lipid Metabolism , Inborn Errors</mesh_term>
	<mesh_term>Ezetimibe</mesh_term>
	<criteria>confirm diagnosis homozygous sitosterolemia establish genotyping clinical parameter pregnant intellectual disability major infectious disease immunodeficiency cancer renal failure diabetes</criteria>
	<gender>All</gender>
	<minimum_age>16 Years</minimum_age>
	<maximum_age>99 Years</maximum_age>
	<verification_date>December 2015</verification_date>
	<keyword>Sitosterolemia</keyword>
	<keyword>Ezetimibe</keyword>
	<keyword>Plant sterol</keyword>
	<keyword>Cholesterol</keyword>
</DOC>